1-14 of 14
Thomas E. Witzig
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Three-Arm Randomized Phase II Study of Bendamustine/Rituximab with Bortezomib Induction or Lenalidomide Continuation in Untreated Follicular Lymphoma: ECOG-ACRIN E2408

Andrew M. Evens, Fangxin Hong, Thomas M. Habermann, Ranjana H. Advani, Randy D. Gascoyne, Thomas E. Witzig, Andrew Quon, Erik A. Ranheim, Stephen M. Ansell, Puneet Singh Cheema, Philip A. Dy, Timothy E. O'Brien, Jane N. Winter, Terrence P. Cescon, Julie E. Chang, Brad S. Kahl
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (17): 4468–4477.
https://doi.org/10.1158/1078-0432.CCR-20-1345
Published: 01 September 2020
View article titled, A Three-Arm Randomized Phase II Study of Bendamustine/Rituximab with Bortezomib Induction or Lenalidomide Continuation in Untreated Follicular Lymphoma: ECOG-ACRIN E2408
Open the PDF for A Three-Arm Randomized Phase II Study of Bendamustine/Rituximab with Bortezomib Induction or Lenalidomide Continuation in Untreated Follicular Lymphoma: ECOG-ACRIN E2408 in another window
Includes: Supplementary data
Journal Articles

A Phase 2/3 Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Lenalidomide Versus Investigator's Choice in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Myron S. Czuczman, Marek Trněný, Andrew Davies, Simon Rule, Kim M. Linton, Nina Wagner-Johnston, Randy D. Gascoyne, Graham W. Slack, Pierre Brousset, David A. Eberhard, Francisco J. Hernandez-Ilizaliturri, Gilles Salles, Thomas E. Witzig, Pier Luigi Zinzani, George W. Wright, Louis M. Staudt, Yandan Yang, P. Mickey Williams, Chih-Jian Lih, Jacqueline Russo, Anjan Thakurta, Patrick Hagner, Pierre Fustier, Dale Song, Ian D. Lewis
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2017) 23 (15): 4127–4137.
https://doi.org/10.1158/1078-0432.CCR-16-2818
Published: 01 August 2017
View article titled, A Phase 2/3 Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Lenalidomide Versus Investigator's Choice in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Open the PDF for A Phase 2/3 Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Lenalidomide Versus Investigator's Choice in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma in another window
Includes: Supplementary data
Journal Articles

Genome-Wide Analysis Uncovers Novel Recurrent Alterations in Primary Central Nervous System Lymphomas

Esteban Braggio, Scott Van Wier, Juhi Ojha, Ellen McPhail, Yan W. Asmann, Jan Egan, Jackline Ayres da Silva, David Schiff, M. Beatriz Lopes, Paul A. Decker, Riccardo Valdez, Raoul Tibes, Bruce Eckloff, Thomas E. Witzig, A. Keith Stewart, Rafael Fonseca, Brian Patrick O'Neill
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (17): 3986–3994.
https://doi.org/10.1158/1078-0432.CCR-14-2116
Published: 31 August 2015
View article titled, Genome-Wide Analysis Uncovers Novel Recurrent Alterations in Primary Central Nervous System Lymphomas
Open the PDF for Genome-Wide Analysis Uncovers Novel Recurrent Alterations in Primary Central Nervous System Lymphomas in another window
Includes: Supplementary data
Journal Articles

A Polymorphism in the Complement Component C1qA Correlates with Prolonged Response Following Rituximab Therapy of Follicular Lymphoma

Emilian Racila, Brian K. Link, Wen-Kai Weng, Thomas E. Witzig, Stephen Ansell, Matthew J. Maurer, Jian Huang, Christopher Dahle, Ahmad Halwani, Ronald Levy, George J. Weiner
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (20): 6697–6703.
https://doi.org/10.1158/1078-0432.CCR-08-0745
Published: 16 October 2008
View article titled, A Polymorphism in the Complement Component <em>C1qA</em> Correlates with Prolonged Response Following Rituximab Therapy of Follicular Lymphoma
Open the PDF for A Polymorphism in the Complement Component <em>C1qA</em> Correlates with Prolonged Response Following Rituximab Therapy of Follicular Lymphoma in another window
Journal Articles

Phase I Clinical Study of Atacicept in Patients with Relapsed and Refractory B-Cell Non–Hodgkin's Lymphoma

Stephen M. Ansell, Thomas E. Witzig, David J. Inwards, Luis F. Porrata, Arnaud Ythier, Lee Ferrande, Ivan Nestorov, Todd DeVries, Stacey R. Dillon, Diana Hausman, Anne J. Novak
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (4): 1105–1110.
https://doi.org/10.1158/1078-0432.CCR-07-4435
Published: 15 February 2008
View article titled, Phase I Clinical Study of Atacicept in Patients with Relapsed and Refractory B-Cell Non–Hodgkin's Lymphoma
Open the PDF for Phase I Clinical Study of Atacicept in Patients with Relapsed and Refractory B-Cell Non–Hodgkin's Lymphoma in another window
Journal Articles

Novel Therapy with 2-Methoxyestradiol for the Treatment of Relapsed and Plateau Phase Multiple Myeloma

S. Vincent Rajkumar, Paul G. Richardson, Martha Q. Lacy, Angela Dispenzieri, Philip R. Greipp, Thomas E. Witzig, Robert Schlossman, Carolyn F. Sidor, Kenneth C. Anderson, Morie A. Gertz
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (20): 6162–6167.
https://doi.org/10.1158/1078-0432.CCR-07-0807
Published: 18 October 2007
View article titled, Novel Therapy with 2-Methoxyestradiol for the Treatment of Relapsed and Plateau Phase Multiple Myeloma
Open the PDF for Novel Therapy with 2-Methoxyestradiol for the Treatment of Relapsed and Plateau Phase Multiple Myeloma in another window
Journal Articles

Randomized Phase II Study of Interleukin-12 in Combination with Rituximab in Previously Treated Non-Hodgkin's Lymphoma Patients

Stephen M. Ansell, Susan M. Geyer, Matthew J. Maurer, Paul J. Kurtin, Ivana N.M. Micallef, Philip Stella, Paul Etzell, Anne J. Novak, Charles Erlichman, Thomas E. Witzig
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (20): 6056–6063.
https://doi.org/10.1158/1078-0432.CCR-06-1245
Published: 24 October 2006
View article titled, Randomized Phase II Study of Interleukin-12 in Combination with Rituximab in Previously Treated Non-Hodgkin's Lymphoma Patients
Open the PDF for Randomized Phase II Study of Interleukin-12 in Combination with Rituximab in Previously Treated Non-Hodgkin's Lymphoma Patients in another window
Journal Articles

Thymidylate Synthase Expression in Colon Carcinomas with Microsatellite Instability

Frank A. Sinicrope, Rafaela L. Rego, Kevin C. Halling, Nathan R. Foster, Daniel J. Sargent, Betsy La Plant, Amy J. French, Carmen J. Allegra, John A. Laurie, Richard M. Goldberg, Thomas E. Witzig, Stephen N. Thibodeau
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (9): 2738–2744.
https://doi.org/10.1158/1078-0432.CCR-06-0178
Published: 04 May 2006
View article titled, Thymidylate Synthase Expression in Colon Carcinomas with Microsatellite Instability
Open the PDF for Thymidylate Synthase Expression in Colon Carcinomas with Microsatellite Instability in another window
Journal Articles

Promising Preclinical Activity of 2-Methoxyestradiol in Multiple Myeloma

David Dingli, Michael Timm, Stephen J. Russell, Thomas E. Witzig, S. Vincent Rajkumar
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (12): 3948–3954.
Published: 01 December 2002
View article titled, Promising Preclinical Activity of 2-Methoxyestradiol in Multiple Myeloma
Open the PDF for Promising Preclinical Activity of 2-Methoxyestradiol in Multiple Myeloma in another window
Journal Articles

Bone Marrow Angiogenesis in 400 Patients with Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, and Primary Amyloidosis

S. Vincent Rajkumar, Ruben A. Mesa, Rafael Fonseca, Georgene Schroeder, Matthew F. Plevak, Angela Dispenzieri, Martha Q. Lacy, John A. Lust, Thomas E. Witzig, Morie A. Gertz, Robert A. Kyle, Stephen J. Russell, Philip R. Greipp
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (7): 2210–2216.
Published: 01 July 2002
View article titled, Bone Marrow Angiogenesis in 400 Patients with Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, and Primary Amyloidosis
Open the PDF for Bone Marrow Angiogenesis in 400 Patients with Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, and Primary Amyloidosis in another window
Journal Articles

Detection of Circulating Cytokeratin-positive Cells in the Blood of Breast Cancer Patients Using Immunomagnetic Enrichment and Digital Microscopy

Thomas E. Witzig, Blaise Bossy, Teresa Kimlinger, Patrick C. Roche, James N. Ingle, Clive Grant, John Donohue, Vera J. Suman, Douglas Harrington, Jose Torre-Bueno, Kenneth D. Bauer
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (5): 1085–1091.
Published: 01 May 2002
View article titled, Detection of Circulating Cytokeratin-positive Cells in the Blood of Breast Cancer Patients Using Immunomagnetic Enrichment and Digital Microscopy
Open the PDF for Detection of Circulating Cytokeratin-positive Cells in the Blood of Breast Cancer Patients Using Immunomagnetic Enrichment and Digital Microscopy in another window
Journal Articles

Prognostic Value of Bone Marrow Angiogenesis in Multiple Myeloma

S. Vincent Rajkumar, Traci Leong, Patrick C. Roche, Rafael Fonseca, Angela Dispenzieri, Martha Q. Lacy, John A. Lust, Thomas E. Witzig, Robert A. Kyle, Morie A. Gertz, Philip R. Greipp
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (8): 3111–3116.
Published: 01 August 2000
View article titled, Prognostic Value of Bone Marrow Angiogenesis in Multiple Myeloma
Open the PDF for Prognostic Value of Bone Marrow Angiogenesis in Multiple Myeloma in another window
Journal Articles

Induction of Apoptosis in Malignant B Cells by Phenylbutyrate or Phenylacetate in Combination with Chemotherapeutic Agents

Thomas E. Witzig, Michael Timm, Mary Stenson, Phyllis A. Svingen, Scott H. Kaufmann
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (2): 681–692.
Published: 01 February 2000
View article titled, Induction of Apoptosis in Malignant B Cells by Phenylbutyrate or Phenylacetate in Combination with Chemotherapeutic Agents
Open the PDF for Induction of Apoptosis in Malignant B Cells by Phenylbutyrate or Phenylacetate in Combination with Chemotherapeutic Agents in another window
Journal Articles

Radioimmunotherapy of Relapsed Non-Hodgkin's Lymphoma with Zevalin, a 90Y-labeled Anti-CD20 Monoclonal Antibody

Gregory A. Wiseman, Christine A. White, Thomas E. Witzig, Leo I. Gordon, Christos Emmanouilides, Andrew Raubitschek, Nalini Janakiraman, John Gutheil, Russell J. Schilder, Stewart Spies, Daniel H. S. Silverman, Antonio J. Grillo-López
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (10): 3281s–3286s.
Published: 01 October 1999
View article titled, Radioimmunotherapy of Relapsed Non-Hodgkin's Lymphoma with Zevalin, a <sup>90</sup>Y-labeled Anti-CD20 Monoclonal Antibody
Open the PDF for Radioimmunotherapy of Relapsed Non-Hodgkin's Lymphoma with Zevalin, a <sup>90</sup>Y-labeled Anti-CD20 Monoclonal Antibody in another window